Tiffany Chen

Tiffany Chen

Auto-generated profile, based on publicly available information

Tiffany Chen

Hackensack Meridian School of Medicine Nutley New Jersey USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2021 in International Forum of Allergy & Rhinology
Verified
Journal Article
Closed access
PDF file
TCTiffany Chen
Tiffany Chen
MSMichael C. Shih
Michael C. Shih
TEThomas S. Edwards
Thomas S. Edwards
SNShaun A. Nguyen
Shaun A. Nguyen
TMTed A. Meyer
Ted A. Meyer
RSRodney J. Schlosser
Rodney J. Schlosser

25 April 2022 in Annals of Otology, Rhinology & Laryngology
Verified
Journal Article
Closed access
TCTiffany Chen
Tiffany Chen
RGRachana Gudipudi
Rachana Gudipudi
SNShaun A. Nguyen
Shaun A. Nguyen
WCWilliam Carroll
William Carroll
CCClarice Clemmens
Clarice Clemmens
Background: Although propranolol has been established as the gold standard when treatment is sought for infantile hemangioma, concerns over its side effect profile have led to increasing usage of atenolol, a beta-1 selective blocker. Methods: A systematic review of PubMed, Scopus, CINAHL, Google Scholar, and Cochrane was conducted following PRISMA guidelines using MeSH terms and keywords for the terms propranolol, atenolol, and infantile hemangioma, including alternative spellings. All randomized control trials (RCTs) or cohort studies directly comparing outcomes of hemangioma treatment with atenolol and propranolol were included. A meta-analysis with pooled mean differences, pooled odds ratios, and analysis of proportions was performed. Results: A total of 669 participants in 7 studies (3 RCTs and 4 cohort) were included. Propranolol showed a significantly higher rate of complete response compared to atenolol (73.3% vs 85.4%, P = .0004). The pooled mean difference of 0.07 (95% CI –0.12, 0.27) in Hemangioma Activity Score (HAS) was not statistically significant. In terms of side effects, there were significantly more agitation and bronchial hyperreactivity events in the propranolol group ( P = .0245 and P < .0001, respectively). Overall, there was a significantly greater number of adverse events in the propranolol group compared to the atenolol group (185 vs 117, P < .00001). The overall pooled odds ratio was 2.70 (95% CI 1.90, 3.84), indicating that there is 2.7 times higher odds of adverse events in the propranolol group. Conclusion: Propranolol treatment leads to a significantly higher rate of complete response than atenolol. However, its use must be weighed against its greater side effect profile.

2 August 2022 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
TCTiffany Chen
Tiffany Chen
SCShreya Chidarala
Shreya Chidarala
GYGabrielle Young
Gabrielle Young
SJSeth S. Jeong
Seth S. Jeong
SNShaun A. Nguyen
Shaun A. Nguyen
RSRodney J. Schlosser
Rodney J. Schlosser

7 April 2021 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
TCTiffany Chen
Tiffany Chen
PAPeter E. Ashman
Peter E. Ashman
DBDennis I. Bojrab
Dennis I. Bojrab
AJAndrew P. Johnson
Andrew P. Johnson
RHRobert S. Hong
Robert S. Hong
PSPeter F. Svider
Peter F. Svider
Eosinophilic Otitis Media (EOM) is a relatively newly defined entity of recurrent and resistant otitis media.To perform a systematic review of otologic manifestations, diagnosis and management of e... 背景:嗜酸性中耳炎(EOM)是复发性和抗药性中耳炎的相对较新定义的实体。目的:对嗜酸性中耳炎(EOM)的耳部表现、诊断和治疗进行系统性的回顾。方法:26项研究中的393例被诊断为EOM的患者符合纳入标准, 并进行了人口统计学、耳科表现、符合诊断标准以及药物和外科治疗方面的评估。结果:最常见的耳科表现为听力下降(65%)、中耳炎伴积液(16%)、鼓膜穿孔(13%)和耳漏(13%)。 93%主要...

8 February 2022 in Annals of Otology, Rhinology & Laryngology
Verified
Journal Article
Closed access
TCTiffany Chen
Tiffany Chen
SPShivani Pathak
Shivani Pathak
EHEllen M. Hong
Ellen M. Hong
BBBrian Benson
Brian Benson
AJAndrew P. Johnson
Andrew P. Johnson
PSPeter F. Svider
Peter F. Svider
Objective: To perform a systematic review to investigate the common presenting symptoms of barosinusitis, the incidence of those findings, the methods for diagnosis, as well as the medical and surgical treatment options. Methods: A review of PubMed/MEDLINE, EMBASE, and Cochrane Library for articles published between 1967 and 2020 was conducted with the following search term: aerosinusitis OR “sinus squeeze” OR barosinusitis OR (barotrauma AND sinusitis) OR (barotrauma AND rhinosinusitis). Twenty-seven articles encompassing 232 patients met inclusion criteria and were queried for demographics, etiology, presentation, and medical and surgical treatments. Results: Mean age of patients was 33.3 years, where 21.7% were females and 78.3% were males. Causes of barotrauma include diving (57.3%), airplane descent (26.7%), and general anesthesia (0.4%). The most common presentations were frontal pain (44.0%), epistaxis (25.4%), and maxillary pain (10.3%). Most patients received topical steroids (44.0%), oral steroids (28.4%), decongestants (20.7%), and antibiotics (15.5%). For surgical treatment, most patients received functional endoscopic sinus surgery (FESS) (49.6%). Adjunctive surgeries include middle meatal or maxillary antrostomy (20.7%), septoplasty (15.5%), and turbinate surgery (9.1%). The most efficacious medical treatments are as follows: 63.6% success rate with oral steroids (66 treated), 50.0% success rate with topical steroids (102 treated), and 50.0% success rate analgesics (10 treated). For surgical treatments received by greater than 10% of the sample, the most efficacious was FESS (91.5% success rate, 108 treated). Conclusion: Oral and topical steroids should be first line therapies. If refractory, then functional endoscopic sinus surgery is an effective treatment.

26 September 2022 in World Journal of Otorhinolaryngology - Head and Neck Surgery
Verified
Journal Article
Open access
TCTiffany Chen
Tiffany Chen
MKMaria Karim
Maria Karim
ZGZachary T. Grace
Zachary T. Grace
AMAndrew R. Magdich
Andrew R. Magdich
ECEric C. Carniol
Eric C. Carniol
PSPeter F. Svider
Peter F. Svider
Objective: To perform a review evaluating management of and complications stemming from dog bite trauma sustained to the head and neck over the past decade.Data Sources: PubMed and Cochrane Library.Methods: The authors searched the PubMed and Cochrane Library databases for relevant published literature. A total of 12 peer‐reviewed canine‐exclusive series inclusive of 1384 patient cases describing facial dog bite trauma met inclusion criteria. Wounds including fractures, lacerations, contusions, and other soft‐tissue injuries were evaluated. Demographics related to clinical course and management, operating room requirements, and antibiotic usage were compiled and analyzed. Initial trauma and surgical management complications were also assessed.Results: 75.5% of patients sustaining dog bites required surgical intervention. Of these patients, 7.8% suffered from postsurgical complications, including hypertrophic scarring (4.3%), postoperative infection (0.8%), or nerve deficits and persistent paresthesias (0.8%). Prophylactic antibiotics were administered to 44.3% of patients treated for facial dog bites and the overall infection rate was 5.6%. Concomitant fracture was present in 1.0% of patients.Conclusion: Primary closure, often in the OR may be necessary, with few cases requiring grafts or flaps. Surgeons should be aware that the most common complication is hypertrophic scarring. Further research is needed to elucidate the role of prophylactic antibiotics.